The value of 11 C-methionine PET in the early differentiation between tumor recurrence and radionecrosis in patients treated for a high-grade glioma and indeterminate MRI-Reference-Cited by-同舟云学术

The value of 11 C-methionine PET in the early differentiation between tumor recurrence and radionecrosis in patients treated for a high-grade glioma and indeterminate MRI

Published:2017-03 Issue:2 Volume:36 Page:85-90
ISSN:2253-8089
Container-title:Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
language:en
Short-container-title:Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Author:

Garcia J.R.,Cozar M.,Baquero M.,Fernández Barrionuevo J.M.,Jaramillo A.,Rubio J.,Maida G.,Soler M.,Riera E.

Publisher

Elsevier BV

Reference26 articles.

1. Neuroimaging in brain tumors;Arbizu;Rev Esp Med Nucl,2011

2. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme;Lee;Int J Radiat Oncol Biol Phys,2009

3. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions;Lilja;Acta Radiol,1989

4. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury;Ogawa;Acta Radiol,1991

5. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET;Chung;Eur J Nucl Med Mol Imaging,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas;Contrast Media & Molecular Imaging;2018-12-02